Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | -99.00% |
2023 | Genocea Biosciences, Inc. Went Out of Business | CI |
2023 | Liquidation Plan Approved for Genocea Biosciences, Inc. | CI |
Financials (USD)
Sales 2020 | 1.36M | Sales 2021 | 1.64M | Capitalization | 66.64M |
---|---|---|---|---|---|
Net income 2020 | -43M | Net income 2021 | -33M | EV / Sales 2020 | 50.8 x |
Net cash position 2020 | 55.9M | Net cash position 2021 | 19.96M | EV / Sales 2021 | 28.4 x |
P/E ratio 2020 |
-2.18
x | P/E ratio 2021 |
-2.4
x | Employees | 74 |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 52 | 07-02-28 | |
Girish Aakalu
PRN | Corporate Officer/Principal | - | 18-12-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ken Bate
CHM | Chairman | 73 | 14-09-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.000001 | 0.00% | 4,500 |
Delayed Quote OTC Markets, May 10, 2024 at 10:56 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-99.00% | 58 | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- GNCAQ Stock